These success, together with a earlier report exhibiting that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like habits in mice,two support the concept of targeting ACKR3 as a novel way to modulate the opioid process, which could open new therapeutic avenues for opioid-related disorders. Importantly, these receptors ended up identified https://edwinh224opq9.wikibriefing.com/user